Evodiamine induces caspase-dependent apoptosis and S phase arrest in human colon lovo cells

Anti-Cancer Drugs

Volumn 21, Issue 8, 2010, Pages 766-776

  Zhang, Chun ^a,b   Fan, Xia ^a   Xu, Xiang ^a   Yang, Xue ^a   Wang, Xi ^a   Liang, Hua Ping ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

apoptosis; caspase; cell cycle; evodiamine; lovo cell

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; CYCLIN A; ENDONUCLEASE G; EVODIAMINE; PROCASPASE 3; PROCASPASE 8; PROCASPASE 9;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE S PHASE; COLON CARCINOMA; FLOW CYTOMETRY; IN VITRO STUDY; IN VIVO STUDY; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR XENOGRAFT; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASES; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; DRUG EVALUATION, PRECLINICAL; DRUGS, CHINESE HERBAL; ENDODEOXYRIBONUCLEASES; FEMALE; HUMANS; MICE; MICE, NUDE; PLANT EXTRACTS; QUINAZOLINES; S PHASE; SIGNAL TRANSDUCTION;

EID: 77955226921     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/CAD.0b013e32833d26a9     Document Type: Article

References (40)

1. Chiou WF, Chou CJ, Shum AY, Chen CF. The vasorelaxant effect of evodiamine in rat isolated mesenteric arteries: mode of action. Eur J Pharmacol 1992; 215:277-283.
2. Choi YH, Shin EM, Kim YS, Cai XF, Lee JJ, Kim HP. Anti-inflammatory principles from the fruits of Evodia rutaecarpa and their cellular action mechanisms. Arch Pharm Res 2006; 29:293-297.
3. Kobayashi Y. The nociceptive and anti-nociceptive effects of evodiamine from fruits of Evodia rutaecarpa in mice. Planta Med 2003; 69:425-428.
4. Takada Y, Kobayashi Y, Aggarwal BB. Evodiamine abolishes constitutive and inducible NF-kB activation by inhibiting IkBa kinase activation, thereby suppressing NF-kB-regulated antiapoptotic and metastatic gene expression, up-regulating apoptosis, and inhibiting invasion. J Biol Chem 2005; 280:17203-1 7212.
5. Chan AL, Chang WS, Chen LM, Lee CM, Chen CE, Lin CM, Hwang JL. Evodiamine stabilizes topoisomerase I-DNA cleavable complex to inhibit topoisomerase I activity. Molecules 2009; 14:1342-1352.
6. Huang DM, Guh JH, Huang YT, Chueh SC, Chiang PC,Teng CM. Induction of mitotic arrest and apoptosis in human prostrate cancer PC-3 cells by evodiamine. J Urol 2005; 173:256-261.
7. Zhang Y, Wu LJ, Tashiro S, Onodera S, Ikejima T. Evodiamine induces A375-S2 cell death through two different pathways. Yao Xue Xue Bao 2003; 38:650-653.
8. Hartwell LH, Weinert TA. Checkpoints: controls that ensure the order of cell cycle events. Science 1989; 246:629-634.
9. Zhou BB, Elledge SJ. The DNA damage response: putting checkpoints in perspective. Nature 2000; 408:433-439.
10. Meeran S, Katiyar S. Cell cycle control as a basis for cancer chemoprevention through dietary agents. Front Biosci 2008; 13:2191-2202.
11. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol 2007; 35:495-516.
12. Lorenzo HK, Susin SA, Penninger J, Kroemer G. Apoptosis inducing factor (AIF): a phylogenetically old, caspase-independent effector of cell death. Cell Death Differ 1999; 6:516-524.
13. Li LY, Luo X, Wang X. Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 2001; 412:95-99.
14. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al. Cancer statistics. CA Cancer J Clin 2006; 56:106-130.
15. Kim YS, Milner JA. Dietary modulation of colon cancer risk. J Nutr 2007; 137 (Suppl):s2576-s2579.
16. Giovannucci E. Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am J of Clin Nutr 2007; 86 (Suppl):s836-s842.
17. Kiyohara C. Genetic polymorphism of enzymes involved in xenobiotic metabolism and the risk of colorectal cancer. J Epidemiol 2000; 10:349-360.
18. Chung KY, Saltz LB. Adjuvant therapy of colon cancer: current status and future directions. Cancer J 2007; 13:192-197.
19. Shahrokni A, Rajebi MR, Saif MW. Toxicity and Efficacy of 5-fluorouracil and capecitabine in a patient with TYMS gene polymorphism: a challenge or a dilemma? Clin Colorectal Cancer 2009; 8:231-234.
20. Ogasawara M, Matsubara T, Suzuki H. Inhibitory effects of evodiamine on in-vitro invasion and experimental lung metastasis of murine colon cancer cells. Biol Pharm Bull 2001; 24:91 7-920.
21. Lin H, Tsai SC, Chen JJ, Chiao YC, Wang SW, Wang GJ, et al. Effects of evodiamine on the secretion of testosterone in rat testicular interstitial cells. Metabolism 1999; 48:1532-1535.
22. Kobayashi Y, Hoshikuma K, Nakano Y, Yokoo Y, Kamiya T. The positive inotropic and chronotropic effects of evodiamine and rutaecarpine, indoloquinazoline alkaloids isolated from the fruits of Evodia rutaecarpa, on the guinea-pig isolated right atria: possible involvement of vanilloid receptors. Planta Med 2001; 67:244-248.
23. Chiou WF, Chen CF. Pharmacological profile of evodiamine in isolated rabbit corpus cavernosum. Eur J Pharmacol 2002; 446:151-159.
24. Kan SF, Huang WJ, Lin LC, Wang PS. Inhibitory effects of evodiamine on the growth of human prostate cancer cell line LNCaP. Int J Cancer 2004; 110:641-651.
25. Yang J, Wu LJ, Tashino SI, Onodera S, Ikejima T. Reactive oxygen species and nitric oxide regulate mitochondria-dependent apoptosis and autophagy in evodiamine-treated human cervix carcinoma HeLa cells. Free Radic Res 2008; 42:492-504.
26. Liao CH, Pan SL, Guh JH, Chang YL, Pai HC, Lin CH, et al. Antitumor mechanism of evodiamine, a constituent from Chinese herb Evodiae fructus, in human multiple-drug resistant breast cancer NCI/ADR-RES cells in vitro and in vivo. Carcinogenesis 2005; 26:968-975.
27. Lowe SW, Lin AW. Apoptosis in cancer. Carcinogenesis 2000; 21:485-495.
28. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetics. Br J Cancer 1972; 26:239-257.
29. Hacker G. The morphology of apoptosis. Cell Tissue Res 2000; 301:5-1 7.
30. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998; 281:1312-1316.
31. Nunez G, Benedict MA, Hu Y, Inohara N. Caspases: the proteases of the apoptotic pathway. Oncogene 1998; 17:3237-3245.
32. Ghobrial I, Witzig T. Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin 2005; 55:178.
33. Cory S, Adams JM. The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2002; 2:647-656.
34. Van Gurp M, Festjens N, Van Loo G, Saelens X, Vandenabeele P. Mitochondrial intermembrane proteins in cell death. Biochem Biophys Res Commun 2003; 304:487-497.
35. Lee TJ, Kim EJ, Kim S, Jung EM, Park JW, Jeong SH, et al. Caspase-dependent and caspase-independent apoptosis induced by evodiamine in human leukemic U937 cells. Mol Cancer Ther 2006; 5:2398-2407.
36. Stewart ZA, Westfall MD, Pietenpol JA. Cell-cycle dysregulation and anticancer therapy. Trends Pharmacol Sci 2003; 24:139-145.
37. Johnson DG, Walker CL. Cyclins and cell cycle checkpoints. Annu Rev Pharmacol Toxicol 1999; 39:295-31 2.
38. Lehner CF, O'Farrell PH. Expression and function of Drosophila cyclin A during embryonic cell cycle progression. Cell 1989; 56:957-968.
39. Girard F, Strausfeld U, Fernandez A, Lamb NJ. Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell 1991; 67:1169-1179.
40. Donzelli M, Draetta G. Regulating mammalian checkpoints through cdc25 inactivation. EMBO Rep 2003; 4:671-677.